Loading…
Attending this event?
Monday, June 17 • 11:00am - 12:00pm
#111: China Town Hall

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Forum
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-24-525-L04-P; CME 1.00; RN 1.00

In this forum, speakers from the National Medical Products Administration (NMPA) and the Center for Drug Evaluation (CDE) and Center for Food and Drug Inspection (CFDI) will present and discuss the latest information on regulation, drug review and approval, and international collaboration. Attendees will have an opportunity to discuss the issues related to drug regulation with NMPA officials.

Learning Objectives

Summarize the latest information on the National Medical Products Administration’s activities in drug regulation and international collaboration; Describe the recent update on the progress in drug review, inspection and approvals in China; Identify challenges in drug regulation in China.

Chair

Ling Su, PhD

Speaker

Opening Remarks and Introductions
Lili Cao, MS

Panelist
Zhimin Yang, MD

Panelist
Jiangyong Yu

Panelist
Shun Lu



Speakers
avatar for Ling Su

Ling Su

Research Fellow, Shenyang Pharmaceutical University, Yeehong Business School, China
Dr. Ling Su is a Research Fellow in Shengyang Pharmaceutical University Yeehong Business School and a Venture Partner in Lilly Asia Ventures (LAV). He has 30 years of experience in drug regulatory and development. He had worked in various R&D management positions in the pharma industry... Read More →
avatar for Lili Cao

Lili Cao

Deputy Director, China Center for Food and Drug International Exchange, National Medical Products, China
avatar for Shun Lu

Shun Lu

Director, Center for Clinical Medicine of Lung Cancer, Shanghai Chest Hospital,, Shanghai Jiaotong University, China
Shun Lu, MD, PhD, is a Director of the Oncology Department and Professor at Shanghai Chest Hospital. Dr. Lu serves on the International Affairs Committee of the American Society of Clinical Oncology, and Multidisciplinary Cancer Management Courses Working Group. He is also a member... Read More →
avatar for Zhimin Yang

Zhimin Yang

Deputy Director, Center for Drug Evaluation, National Medical Products Administration (NMPA), China
Dr. Yang is the head of the Medical Review Department I, Centre for Drug Evaluation (CDE), National Medical Products Administration (NMPA), China. Graduated from Peking University, she first worked as pediatrics physician in PKU People’s Hospital for 8 years, and joined CDE as medical... Read More →
JY

Jiangyong Yu

Director, Department of Drug Registration, National Medical Products Administration (NMPA), China


Monday June 17, 2024 11:00am - 12:00pm PDT
Room 6D San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA
  09: Regulatory, Forum